MedPage Today on MSN
First-in-class KRAS-degrader promising in pancreatic, lung cancers
"There is a clear unmet need for therapies," researcher says ...
Successful meeting with FDA enables advancement into proposed Phase 3 clinical trial of VCN-01 in combination with gemcitabine/nab-paclitaxel ...
Rosalind Franklin University announced today that Paige Arneson-Wissink, PhD, assistant professor of biochemistry and ...
Theriva Biologics has received FDA agreement on the core design elements of a pivotal phase 3 trial evaluating zabilugene ...
(A) Bar plot of IARS2 transcription level in different cancer types. (B) TCGA and GTEx databases showed IARS2 transcription level was higher in tumor tissue compared with normal pancreas tissue. (C) ...
A new preclinical study in mice shows that precancerous cells in the pancreas can be eliminated before they have the chance to become tumors. Using an experimental therapy to target microscopic ...
Long-Term Survival and Biomarker Analysis Evaluating Neoadjuvant Plus Adjuvant Relatlimab (anti-LAG3) and Nivolumab (anti-PD1) in Patients With Resectable Melanoma Our study included a broad cohort of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results